Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 676,844 | 730,239 | 680,800 | 691,099 | 700,062 |
| Cost of Goods | 314,427 | 333,172 | 308,233 | 296,068 | 297,427 |
| Gross Profit | 362,417 | 397,067 | 372,567 | 395,031 | 402,635 |
| Operating Expenses | 300,931 | 278,585 | 278,154 | 272,207 | 256,654 |
| Operating Income | 61,913 | 118,654 | 94,646 | 122,892 | 146,408 |
| Interest Expense | 12,337 | 11,669 | 11,663 | 10,720 | 4,048 |
| Other Income | 35,253 | 984,370 | -290,301 | -1,332,377 | -4,510,392 |
| Pre-tax Income | 84,829 | 1,091,355 | -207,318 | -1,220,205 | -4,368,032 |
| Income Tax | 15,867 | 263,586 | -44,510 | -295,091 | -1,000,685 |
| Net Income Continuous | 68,962 | 827,769 | -162,808 | -925,114 | -3,367,347 |
| Net Income | $68,962 | $827,769 | $-162,808 | $-925,114 | $-3,367,347 |
| EPS Basic Total Ops | 2.33 | 27.24 | -5.48 | -31.05 | -112.50 |
| EPS Basic Continuous Ops | 2.33 | 27.23 | -5.48 | -31.05 | -112.50 |
| EPS Diluted Total Ops | 2.32 | 27.24 | -5.48 | -31.05 | -112.50 |
| EPS Diluted Continuous Ops | 2.32 | 27.23 | -5.48 | -31.05 | -112.50 |
| EBITDA(a) | $61,913 | $118,654 | $94,646 | $122,892 | $146,408 |